Among these NLRP3 inhibitors, tranilast, β-hydroxybutyrate, paeoniflorin, coptisine, BAY 11-7082, and Bifidobacterium longum have a possible role in IBS symptom management [84]. Here, NLRP3 is linked to irritable bowel syndrome.